![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Shandong New Time Pharmaceutical Co., Ltd. Linyi Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Isosorbide mononitrate, diluted, 70%, 60%, 50%, 40% in lactose monohydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2020-153 - Rev 00
This Chemical Type CEP, issued on May 11, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1118 associated with this CEP further emphasizes